Article révisé par les pairs
Titre:
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.
Auteur:Gonzalez-Ericsson, Paula I; Stovgaard, Elisabeth ES; Sua, Luz F; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O; Laenkholm, Anne-Vibeke; Fox, Stephen B; Adam, Julien; Bartlett, John Ms; Rimm, David L; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I; Balko, Justin M; Haynes, Harry HR; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos Altamirano; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen A.M.; Viale, Giuseppe; Schnitt, Stuart J; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen M; Thompson, E Aubrey; Allison, Kimberly H; Symmans, William Fraser; Bellizzi, Andrew M; Brogi, Edi; Moore, David A; Larsimont, Denis; Dillon, Deborah A; Lazar, Alexander; Lien, Huangchun; Goetz, Matthew P; Broeckx, Glenn; El Bairi, Khalid; Harbeck, Nadia; Cimino-Mathews, Ashley; Sotiriou, Christos; Adams, Sylvia; Liu, Shi-Wei; Loibl, Sibylle; Chen, I-Chun; Lakhani, Sunil R; Juco, Jonathan W; Denkert, Carsten; Blackley, Elizabeth EF; Demaria, Sandra; Leon-Ferre, Roberto; Gluz, Oleg; Zardavas, Dimitrios; Emancipator, Kenneth; Ely, Scott; Loi, Sherene; Salgado, Roberto; Sanders, Melinda M.E.; International Immuno-Oncology Biomarker Working Group,
Informations sur la publication:Journal of pathology
Statut de publication:Publié, 2020-03-01
Sujet CREF:Cancérologie
Sciences bio-médicales et agricoles
Médecine pathologie humaine
Mots-clés:PD-L1
TILs
biomarker risk-management
breast cancer
immunotherapy
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:0022-3417
info:doi/10.1002/path.5406
info:scp/85083463990
info:pmid/32129476

Documents en relation

DI-fusion

  • Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
    par Hudeček, Jan , Voorwerk, Leonie , van Seijen, Maartje , Nederlof, Iris , de Maaker, Michiel , van den Berg, Jose , van de Vijver, Koen K , Sikorska, Karolina , Adams, Sylvia , Demaria, Sandra , Viale, Giuseppe , Nielsen, Torsten O , Badve, Sunil , Michiels, Stefan , Symmans, William Fraser , Sotiriou, Christos , Rimm, David L , Hewitt, Stephen M , Denkert, Carsten , Loibl, Sibylle , Loi, Sherene , Bartlett, John M S , Pruneri, Giancarlo , Dillon, Deborah A , Cheang, Maggie C U , Tutt, Andrew M , Hall, Jacqueline Anne , Kos, Zuzana , Salgado, Roberto , Kok, Marleen , Horlings, Hugo Mark , International Immuno-Oncology Biomarker Working Group
    Publication 2020-01-01
  • The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
    par El Bairi, Khalid , Haynes, Harry R , Blackley, Elizabeth EF , Fineberg, Susan , Shear, Jeffrey , Turner, Sophia , de Freitas, Juliana Ribeiro , Sur, Daniel , Amendola, Luis Claudio , Gharib, Masoumeh , Kallala, Amine , Arun, Indu , Azmoudeh-Ardalan, Farid , Fujimoto, Luciana , Sua, Luz F , Liu, Shi-Wei , Lien, Huang-Chun , Kirtani, Pawan , Balancin, Marcelo , El Attar, Hicham , Guleria, Prerna , Yang, Wenxian , Shash, Emad , Chen, I-Chun , Bautista, Veronica , Do Prado Moura, Jose Fernando , Rapoport, Bernardo Leon B. , Castaneda, Carlos , Spengler, Eunice , Acosta-Haab, Gabriela , Frahm, Isabel , Sanchez, Joselyn , Castillo, Miluska , Bouchmaa, Najat , Md Zin, Reena RR , Shui, Ruohong , Onyuma, Timothy , Yang, Wentao , Husain, Zaheed , Willard-Gallo, Karen , Coosemans, Alphonse , Perez, Edith A , Provenzano, Elena , Ericsson, Paula Gonzalez , Richardet, Eduardo , Mehrotra, Ravi , Sarancone, Sandra , Ehinger, Anna , Rimm, David L , Bartlett, John M S , Viale, Giuseppe , Denkert, Carsten , Hida, Akira I , Sotiriou, Christos , Loibl, Sibylle , Hewitt, Stephen M , Badve, Sunil , Symmans, William Fraser , Kim, Seong-Rim , Pruneri, Giancarlo , Goel, Shom , Francis, Prudence A , Inurrigarro, Gloria , Yamaguchi, Rin , Garcia-Rivello, Hernan , Horlings, Hugo Mark , Afqir, Said , Salgado, Roberto , Adams, Sylvia , Kok, Marleen , Dieci, Maria Vittoria , Michiels, Stefan , Demaria, Sandra , Loi, Sherene , International Immuno-Oncology Biomarker Working Group
    Publication 2021-12-01
  • Incorporation of TILs in daily breast cancer care: how much evidence can we bear?
    par Lænkholm, Anne Vibeke , Callagy, Grace , Balancin, Marcelo , Bartlett, John J.M.S. , Sotiriou, Christos , Marchio, Caterina , Kok, Marleen , Dos Anjos, Carlos Henrique , Salgado, Roberto
    Publication 2022-02-01
  • Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
    par Loi, Sherene , Salgado, Roberto , Adams, Sylvia , Pruneri, Giancarlo , Francis, Prudence P.A. , Lacroix-Triki, Magali , Joensuu, Heikki , Dieci, Maria Vittoria , Badve, Sunil , Demaria, Sandra , Gray, Robert , Munzone, Elisabetta , Drubay, Damien , Lemonnier, Jerome , Sotiriou, Christos , Kellokumpu-Lehtinen, Pirkko-Liisa , Vingiani, Andrea , Gray, Kathryn , Andre, Fabrice , Denkert, Carsten , Piccart-Gebhart, Martine , Roblin, Elvire , Michiels, Stefan
    Publication 2022-12
  • Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trial
    par Rediti, Mattia , Venet, David , Joaquin Garcia, Andrea , Maetens, Marion M. , Vincent, Delphine , Majjaj, Samira , El-abed, Sarra , Di Cosimo, Serena , Ueno, Takayuki , Izquierdo, Miguel , Piccart-Gebhart, Martine , Pusztai, Lajos , Loi, Sherene , Salgado, Roberto , Viale, Giuseppe , Rothé, Françoise , Sotiriou, Christos
    Publication 2024-12-01